DR. MARK HALLETT, M.D.
Neurology at Westbard Ave, Bethesda, MD
License number
Maryland D0008859
Category
Neurology
Type
Neurology
License number
Maryland D0008859
Category
Neurology
Type
Clinical Neurophysiology
Address
Address
5147 Westbard Ave, Bethesda, MD 20816
Phone
(301) 496-9526
(301) 480-2286 (Fax)
(301) 229-2706
(301) 480-2286 (Fax)
(301) 229-2706
Personal information
See more information about MARK HALLETT at radaris.comName
Address
Phone
5147 Westbard Ave, Bethesda, MD 20816
806 Kimberly Way, Stevensville, MD 21666
5147 Westbard Ave, Bethesda, MD 20816
Organization information
See more information about MARK HALLETT at bizstanding.comNational Institutes Of Health - Mark Hallett MD
10 Ctr Dr BLDG 10, Bethesda, MD 20892
Categories:
Neurology Physicians & Surgeons
Phone:
(301) 496-9526 (Phone)
Professional information
See more information about MARK HALLETT at trustoria.com
Dr. Mark Hallett, Bethesda MD - MD (Doctor of Medicine)
Dr. Mark Hallett, Bethesda MD - MD (Doctor of Medicine)
Specialties:
Clinical Neurophysiology
Address:
Movement Dsrdrs Fllwshp NIH
10 Ctr Dr SUITE 10RM7D36, Bethesda 20892
(301) 496-9526 (Phone)
10 Ctr Dr SUITE 10RM7D36, Bethesda 20892
(301) 496-9526 (Phone)
Certifications:
Clinical Neurophysiology, 2001, Neurology, 1977
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Harvard Medical School
Graduated: 1969
Brigham and Women's Hospital
Graduated: 1970
Massachusetts General Hospital
Graduated: 1975
Institute Psychology
Graduated: 1976
Nimh
Graduated: 1972
Harvard Medical School
Graduated: 1969
Brigham and Women's Hospital
Graduated: 1970
Massachusetts General Hospital
Graduated: 1975
Institute Psychology
Graduated: 1976
Nimh
Graduated: 1972
Mark Hallett, Bethesda MD
Mark Hallett, Bethesda MD
Specialties:
Neurologist
Address:
10 Center Dr, Bethesda, MD 20892
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology), American Board of Psychiatry and Neurology Sub-certificate in Clinical Neurophysiology (Psychiatry and Neurology)
Coil For Magnetic Stimulation
Coil For Magnetic Stimulation
US Patent:
7407478, Aug 5, 2008
Filed:
Oct 19, 2001
Appl. No.:
10/399559
Inventors:
Abraham Zangen - Jerusalem, IL
Roy A. Wise - Baltimore MD, US
Mark Hallett - Bethesda MD, US
Pedro Cavaleiro Miranda - Lisbon, PT
Yiftach Roth - Ramat-Gan, IL
Roy A. Wise - Baltimore MD, US
Mark Hallett - Bethesda MD, US
Pedro Cavaleiro Miranda - Lisbon, PT
Yiftach Roth - Ramat-Gan, IL
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61N 1/00
US Classification:
600 13, 600 15
Abstract:
A magnetic stimulator, which may be used as a transcranial magnetic stimulation (TMS) device, and a method for its use are disclosed. The stimulator comprises a frame and an electrically conductive coil having a partially toroidal or ovate base and an outwardly projecting extension portion. The frame may be a flexible or malleable material and may be non-conductive. The electrically conductive coil may comprise one or more windings of electrically conductive material (such as a wire) coupled to the frame. The coil is electrically connected to a power supply. The device may be placed adjacent to or in contact with the body of a subject, such as on the head of a subject. The device may be used on humans for treating certain physiological conditions, such as cardiovascular or neurophysiological conditions, or for studying the physiology of the body. This device is useful in studying or treating neurophysiological conditions associated with the deep regions of the brain, such as drug addiction and depression.
Coil For Magnetic Stimulation And Methods For Using The Same
Coil For Magnetic Stimulation And Methods For Using The Same
US Patent:
8608634, Dec 17, 2013
Filed:
Mar 21, 2008
Appl. No.:
12/077829
Inventors:
Abraham Zangen - Jerusalem, IL
Roy A. Wise - Baltimore MD, US
Mark Hallett - Bethesda MD, US
Pedro Cavaleiro Miranda - Lisbon, PT
Yiftach Roth - Ramat-Gan, IL
Roy A. Wise - Baltimore MD, US
Mark Hallett - Bethesda MD, US
Pedro Cavaleiro Miranda - Lisbon, PT
Yiftach Roth - Ramat-Gan, IL
Assignee:
The United States of America, as represented by the Secretary, Department of Health and Human Services - Washington DC
International Classification:
A61N 1/00
US Classification:
600 15
Abstract:
A magnetic stimulator, which may be used as a transcranial magnetic stimulation (TMS) device, and a method for its use are disclosed. The stimulator comprises a frame and an electrically conductive coil having a partially toroidal or ovate base and an outwardly projecting extension portion. The frame may be a flexible or malleable material and may be nonconductive. The electrically conductive coil may comprise one or more windings of electrically conductive material (such as a wire) coupled to the frame. The coil is electrically connected to a power supply. The device may be placed adjacent to or in contact with the body of a subject, such as on the head of a subject. The device may be used on humans for treating certain physiological conditions, such as cardiovascular or neurophysiological conditions, or for studying the physiology of the body. This device is useful in studying or treating neurophysiological conditions associated with the deep regions of the brain, such as drug addiction and depression.
Immunotoxin (Mab-Ricin) For The Treatment Of Focal Movement Disorders
Immunotoxin (Mab-Ricin) For The Treatment Of Focal Movement Disorders
US Patent:
2002008, Jun 27, 2002
Filed:
Nov 7, 2001
Appl. No.:
10/005512
Inventors:
Jonathan Hott - Birmingham MI, US
Richard Youle - Bethesda MD, US
Mark Hallett - Bethesda MD, US
Marinos Dalakas - Bethesda MD, US
Richard Youle - Bethesda MD, US
Mark Hallett - Bethesda MD, US
Marinos Dalakas - Bethesda MD, US
Assignee:
The Gov. of the U.S.A. as represented by the Secre tary of the Dept. of Health and Human Services - Rockville MD
International Classification:
A61K039/395
US Classification:
424/178100
Abstract:
Compositions and methods for treatment of focal muscle spasms. Immunotoxin conjugates comprise a toxin conjugated to an antibody reactive to a muscle specific antigen.
Immunotoxin (Mab-Ricin) For The Treatment Of Focal Movement Disorders
Immunotoxin (Mab-Ricin) For The Treatment Of Focal Movement Disorders
US Patent:
2005026, Dec 1, 2005
Filed:
Jul 9, 2004
Appl. No.:
10/886557
Inventors:
Jonathan Hott - Birmingham MI, US
Richard Youle - Bethesda MD, US
Mark Hallett - Bethesda MD, US
Marinos Dalakas - Bethesda MD, US
Richard Youle - Bethesda MD, US
Mark Hallett - Bethesda MD, US
Marinos Dalakas - Bethesda MD, US
International Classification:
A61K039/395, A61K035/78
US Classification:
424178100, 424731000
Abstract:
Compositions and methods for treatment of focal muscle spasms. Immunotoxin conjugates comprise a toxin conjugated to an antibody reactive to a muscle specific antigen.
Octanoic Acid Formulations And Methods Of Treatment Using The Same
Octanoic Acid Formulations And Methods Of Treatment Using The Same
US Patent:
2011011, May 12, 2011
Filed:
Feb 12, 2009
Appl. No.:
12/867702
Inventors:
Mark Hallett - Bethesda MD, US
John A. McLane - Warwick RI, US
Fatta B. Nahab - Gaithersburg MD, US
John A. McLane - Warwick RI, US
Fatta B. Nahab - Gaithersburg MD, US
Assignee:
The Government of the United States of America, as represented by The National Institutes of Health - Rockville MD
Ariston Pharmaceuticals - Framingham MA
Ariston Pharmaceuticals - Framingham MA
International Classification:
A61K 38/16, A61K 31/20, A61K 31/5513, A61K 31/23, A61K 31/7028, A61P 25/16, A61P 5/16, A61P 25/08, A61P 1/16
US Classification:
514 11, 514558, 514221, 514552, 514 25
Abstract:
The invention features pharmaceutical formulations containing octanoic acid or a salt or ester thereof. The pharmaceutical formulations are useful for the treatment of involuntary tremors.
Octanol Formulations And Methods Of Treatment Using The Same
Octanol Formulations And Methods Of Treatment Using The Same
US Patent:
2009021, Aug 27, 2009
Filed:
Oct 5, 2006
Appl. No.:
12/083141
Inventors:
Fatta B. Nahab - Gaithersburg MD, US
Mark Hallett - Bethesda MD, US
Jeff Serbin - New York City NY, US
John A. McLane - Warwick RI, US
Mark Hallett - Bethesda MD, US
Jeff Serbin - New York City NY, US
John A. McLane - Warwick RI, US
International Classification:
A61K 31/045, A61K 31/23
US Classification:
514552, 514724
Abstract:
The invention features pharmaceutical formulations containing octanol and esters thereof. The pharmaceutical formulations are useful for the treatment of involuntary tremors.